Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13–stimulated airway epithelial cells
Maude A. Liegeois, Margaret Braunreuther, Annabelle R. Charbit, Wilfred W. Raymond, Monica Tang, Prescott G. Woodruff, Stephanie A. Christenson, Mario Castro, Serpil C. Erzurum, Elliot Israel, Nizar N. Jarjour, Bruce D. Levy, Wendy C. Moore, Sally E. Wenzel, Gerald G. Fuller, John V. Fahy
Maude A. Liegeois, Margaret Braunreuther, Annabelle R. Charbit, Wilfred W. Raymond, Monica Tang, Prescott G. Woodruff, Stephanie A. Christenson, Mario Castro, Serpil C. Erzurum, Elliot Israel, Nizar N. Jarjour, Bruce D. Levy, Wendy C. Moore, Sally E. Wenzel, Gerald G. Fuller, John V. Fahy
View: Text | PDF
Research Article Cell biology Pulmonology

Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13–stimulated airway epithelial cells

  • Text
  • PDF
Abstract

Mucus plugs occlude airways to obstruct airflow in asthma. Studies in patients and in mouse models show that mucus plugs occur in the context of type 2 inflammation, and studies in human airway epithelial cells (HAECs) show that IL-13–activated cells generate pathologic mucus independently of immune cells. To determine how HAECs autonomously generate pathologic mucus, we used a magnetic microwire rheometer to characterize the viscoelastic properties of mucus secreted under varying conditions. We found that normal HAEC mucus exhibited viscoelastic liquid behavior and that mucus secreted by IL-13–activated HAECs exhibited solid-like behavior caused by mucin cross-linking. In addition, IL-13–activated HAECs shows increased peroxidase activity in apical secretions, and an overlaid thiolated polymer (thiomer) solution shows an increase in solid behavior that was prevented by peroxidase inhibition. Furthermore, gene expression for thyroid peroxidase (TPO), but not lactoperoxidase (LPO), was increased in IL-13–activated HAECs and both TPO and LPO catalyze the formation of oxidant acids that cross-link thiomer solutions. Finally, gene expression for TPO in airway epithelial brushings was increased in patients with asthma with high airway mucus plug scores. Together, our results show that IL-13–activated HAECs autonomously generated pathologic mucus via peroxidase-mediated cross-linking of mucin polymers.

Authors

Maude A. Liegeois, Margaret Braunreuther, Annabelle R. Charbit, Wilfred W. Raymond, Monica Tang, Prescott G. Woodruff, Stephanie A. Christenson, Mario Castro, Serpil C. Erzurum, Elliot Israel, Nizar N. Jarjour, Bruce D. Levy, Wendy C. Moore, Sally E. Wenzel, Gerald G. Fuller, John V. Fahy

×

Figure 5

Cross-linking of a thiomer solution placed on the apical surface of IL-13–activated HAECs is prevented by inhibiting peroxidase activity.

Options: View larger image (or click on image) Download as PowerPoint
Cross-linking of a thiomer solution placed on the apical surface of IL-1...
(A) Schematic illustrating how the thiomer solution was overlaid on the apical side of human airway epithelial cells (HAECs) at air-liquid interface (ALI) culture under control and IL-13 activation conditions. A methimazole condition tested the effect of peroxidase inhibition on thiomer cross-linking in IL-13–activated HAECs. (B) Data from 4 donors showing creep compliance over time of thiomer solutions overlaid on the apical surface of HAECs in control conditions, IL-13 conditions, and methimazole conditions. (C) Summarized steady-state creep compliance of thiomer solutions overlaid on HAECs in control conditions, IL-13 conditions, and methimazole conditions. (D) Summarized zero-shear viscosity of thiomer solutions overlaid on HAECs in control conditions, IL-13 conditions, and methimazole conditions. For C and D, the boxes show the interquartile ranges, while the error bars show the minimum and maximum values. Each symbol represents 1 donor (n = 4), and data are represented as the mean value of independent measurements from 2 or 3 transwell inserts of the same condition. P values were calculated using a ratio paired Student’s t test. Significantly different from control conditions, *P < 0.05; significantly different from control conditions, **P < 0.01; significantly different from IL-13 conditions, ##P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts